Current Management of Superficial Bladder Cancer, An Issue of Urologic Clinics of North America
- 1st Edition, Volume 53-3 - July 1, 2026
- Latest edition
- Editor: Mark L. Gonzalgo
- Language: English
In this issue of Urologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic of Current Management of Superficial Bladder C… Read more
Purchase options
Description
Description
In this issue of Urologic Clinics of North America, guest editor Dr. Mark L. Gonzalgo brings his considerable expertise to the topic of Current Management of Superficial Bladder Cancer. Non–muscle-invasive bladder cancer (NMIBC) represents approximately 75% of newly diagnosed bladder cancer cases, making its management a critical focus for urologists worldwide. In this issue, top experts address the evolving landscape of NMIBC care, from innovations in urinary biomarkers and enhanced cystoscopy techniques to advancements in intravesical therapies and personalized molecular treatment.
Key features
Key features
- Contains 14 relevant, practice-oriented topics, including emerging intravesical therapies for NMIBC; management of high-risk NMIBC; economic considerations in the management of superficial bladder cancer; artificial intelligence and digital tools in bladder cancer care; key clinical trials shaping the future of superficial bladder cancer management; and more
- Provides in-depth clinical reviews on current management of superficial bladder cancer, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Readership
Readership
Urology
Table of contents
Table of contents
Epidemiology and Risk Factors for Non–Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis
Advances in Diagnosis of Non–Muscle-Invasive Bladder Cancer: A Review
Transurethral Resection of Bladder Tumors: Evolving Standards of Care—Optimizing Resection, Staging Accuracy, and Recurrence Reduction
Role of Enhanced Imaging in Superficial Bladder Cancer Management
Emerging Intravesical Therapies for Non–Muscle-Invasive Bladder Cancer
Bacillus Calmette-Gue´ rin Therapy: Optimizing Outcomes amid Challenges
Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer
Management of High-Risk Non-Muscle-Invasive Bladder Cancer
Surveillance Protocols: Balancing Patient Burden and Cancer Control
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non–muscle-invasive Disease
Patient-Centered Approaches to Non–Muscle-Invasive Bladder Cancer Care
Economic Considerations in the Management of Superficial Bladder Cancer
Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care
Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management
Advances in Diagnosis of Non–Muscle-Invasive Bladder Cancer: A Review
Transurethral Resection of Bladder Tumors: Evolving Standards of Care—Optimizing Resection, Staging Accuracy, and Recurrence Reduction
Role of Enhanced Imaging in Superficial Bladder Cancer Management
Emerging Intravesical Therapies for Non–Muscle-Invasive Bladder Cancer
Bacillus Calmette-Gue´ rin Therapy: Optimizing Outcomes amid Challenges
Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer
Management of High-Risk Non-Muscle-Invasive Bladder Cancer
Surveillance Protocols: Balancing Patient Burden and Cancer Control
Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non–muscle-invasive Disease
Patient-Centered Approaches to Non–Muscle-Invasive Bladder Cancer Care
Economic Considerations in the Management of Superficial Bladder Cancer
Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care
Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 53-3
- Published: July 1, 2026
- Language: English
About the editor
About the editor
MG
Mark L. Gonzalgo
Affiliations and expertise
Professor and Vice Chair Director, Urologic Oncology Fellowship Desai Sethi Urology Institute University of Miami Miller School of Medicine Executive Director, Perioperative Surgical Services University of Miami Health System Miami, FL, USA